Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents.
about
Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia.Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesHematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageStrategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma.Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantationHematopoietic stem cell transplantation in peripheral T-cell lymphomas.Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation.Changing the treatment paradigm in myelodysplastic syndromes.What is the role for donor natural killer cells after nonmyeloablative conditioning?Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia.Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies.Promising role of reduced-toxicity hematopoietic stem cell transplantation (PART-I).Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?Current state of art for transplantation paradigms in peripheral T-cell lymphomas.Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!Complications of allogeneic hematopoietic stem cell transplantation.Reduced intensity transplantation for primary immunodeficiency disorders.Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy.Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML.Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors.Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies.
P2860
Q30884173-57963E75-DDF4-45EF-8FCA-F2A29700CF80Q33611146-689FF0A9-F8A1-4A6E-93B2-BB2035AF3E9AQ33770125-84982BEF-2E74-4658-8693-0A55FF851BEEQ33771667-73FD772D-5273-4337-B391-492C8862B3AFQ33795160-CC4F860E-35B9-4F20-9F1B-801759873BBBQ33841129-ADFD31E2-7083-44CF-91A4-B6C50B444A0AQ33859061-380816EA-8180-4BAE-B01D-CCAC0962DFA9Q33999284-C8C4B427-4729-4403-86C6-D727999EDA5DQ34348102-4440019B-C513-493E-BC1C-C8A825FFFD3EQ34543056-337496AD-EC02-48A8-BBFA-3CA42CE495CFQ34622755-0B226227-34AB-4F8B-9A76-68724824D916Q35166811-D6A3C223-880A-48CB-B153-83D5F7CA555EQ36055095-2F709E39-7618-49DB-83CF-E69B65997DCDQ36528822-A1CAF34B-AD88-4C5C-A621-D941790DBDE4Q36837761-5BF92E85-1455-4089-8668-21D8683F346CQ36837765-585754BE-9A29-412B-BA9F-8CBF5D1C5401Q36911495-10329A3C-6A9A-4FCE-8799-BFEE4E4F8673Q36994811-C2B29371-E846-4C79-A901-CF42C89CE687Q37132892-5A79ADF9-1D43-43A3-8FB2-2320CB0D2D76Q37277994-DF3242FE-CC96-484D-8E48-5561AB5BB445Q37327327-161279DB-5197-453F-A93D-6BE572089743Q37919867-EF0C435B-BB9A-43DA-9BD4-5E90CF41E5ADQ37990549-EAC81151-9FE6-4351-9E41-9C74EFDCF42BQ38029953-763B4574-E0A3-4D5C-8A59-E6A56ADDFB89Q38087853-66057694-F57C-42D3-A1E9-A794A0693FE2Q38132821-29FB1555-E078-45FA-A002-5AA823F8D15CQ38179975-0A09BD86-1DDE-41BA-9227-FDD2E9C96C68Q38217938-DB0BC052-C5DB-481D-B882-3844A12FD1CAQ38912369-DDC9BDEA-25F9-4EB2-9384-59EB860CBC8EQ39414681-4F031C1B-0314-4B7D-AE7E-38F375A4107FQ40216218-99DE1CB5-5E56-402D-9FBA-6FE10F14E5C6Q43616985-B8D2B862-3759-4B90-9C00-1EDDA6D85AAAQ44113778-1B1E7D4E-C930-4FCC-B51B-FB6FFA002C10Q46761676-F7F20E80-9307-4063-9EF0-F808F08F5785Q47928634-38602CBA-9437-4926-A065-56445E8C5D67Q53615862-535D4A32-28A3-469B-83E7-45752D7C645B
P2860
Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Stem cell transplantation with ...... ts and new therapeutic agents.
@ast
Stem cell transplantation with ...... ts and new therapeutic agents.
@en
type
label
Stem cell transplantation with ...... ts and new therapeutic agents.
@ast
Stem cell transplantation with ...... ts and new therapeutic agents.
@en
prefLabel
Stem cell transplantation with ...... ts and new therapeutic agents.
@ast
Stem cell transplantation with ...... ts and new therapeutic agents.
@en
P2860
P356
P1433
P1476
Stem cell transplantation with ...... ts and new therapeutic agents.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404334
P577
2006-07-27T00:00:00Z
P5875
P6179
1051230583